Filapixant;B35HB63WZF;3-{[(2R)-4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide;Filapixant [INN];BDBM320181;US10174016, Example 348;Benzamide, 3-(((2R)-4-methyl-2-morpholinyl)methoxy)-5-(5-methyl-2-thiazolyl)-N-((1R)-1-(2-(trifluoromethyl)-5-pyrimidinyl)ethyl)-
Filapixant is a purinoreceptor antagonist extracted from patent WO2016091776A1, example 348. Filapixant is the active reference substance of Eliapixant.
性状
Solid
IC50 & Target[1][2]
purinoreceptor
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;In solvent -80°C 6 months
参考文献
[1]. Davenport AJ, et, al. 1,3-thiazol-2-yl substituted benzamides. WO2016091776A1.
溶解度数据
In Vitro: DMSO : 146.67 mg/mL (281.21 mM; Need ultrasonic)配制储备液